NASDAQ NMS - GLOBAL MARKET · LTRN
+3.93% · +$0.0900 · Vol 185.1K
Market closed · last close 4:00 PM ET · price as of 18:52:44 ET
Lantern Pharma Inc

Lantern Pharma Inc

Biotechnology
$2.38
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
LTRN
Lantern Pharma Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is LTRN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading LTRN catalysts
About Lantern Pharma Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2020
Employees
16
Country
US

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.32
Day high
$2.41
Day low
$2.13
Previous close
$2.29
52W high
$4.62
-48.48% from high
52W low
$1.12
36% of range
Market cap
$29.9M
EPS
$-1.6800
Beta
2.15
Shares out
12.8M
Volume
185.1K
1.82× rel vol
Avg volume
101.5K
VWAP
$2.31
Price history computed in-house
1W
-8.46%
1M
-13.45%
3M
-29.59%
1Y
-47.23%
YTD
-21.45%
SMA 50 $3.17 · below
SMA 200 $2.99 · below
52W position 36%

LTRN overview

Veridion Score
59
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around LTRN.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading LTRN Form 4 filings
Public disclosures

Congress activity in LTRN

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for LTRN in the cached public ledger.

Federal contracts

LTRN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for LTRN in this window.
Lobbying spend

LTRN lobbying filings, year to date.

Registered lobbying filings matched to Lantern Pharma Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for LTRN in this window.
Loading news for LTRN
Analyst ratings
Sovereign unlock shows live analyst consensus for LTRN.
Options
Sovereign unlock shows live options positioning for LTRN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.